Kallmeyer, A., Pello, A., Cánovas, E., Aceña Navarro, Á., González-Casaus, M. L., Tarín, N., . . . Tuñón Fernández, J. L. (2023). Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
Citación estilo ChicagoKallmeyer, Andrea, et al. Fibroblast Growth Factor 23 Independently Predicts Adverse Outcomes After an Acute Coronary Syndrome. 2023.
Cita MLAKallmeyer, Andrea, et al. Fibroblast Growth Factor 23 Independently Predicts Adverse Outcomes After an Acute Coronary Syndrome. 2023.
Precaución: Estas citas no son 100% exactas.